Efi Makdasi
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 3
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 3
-
- Bacillus and Francisella bacterial research 4
-
- Animal Virus Infections Studies 4
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Ronit RosenfeldNir ParanYfat Yahalom-RonenErez Bar‐HaimHadas TamirOfer CohenRon AlcalayUri Elia
- Partner nations
- IsraelUnited States
In The Last Decade
Efi Makdasi
27 papers receiving 292 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 127
- Immunology 90
- Virology 19
- Modeling and Simulation 11
- Molecular Biology 143
Countries citing papers authored by Efi Makdasi
This map shows the geographic impact of Efi Makdasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efi Makdasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efi Makdasi more than expected).
Fields of papers citing papers by Efi Makdasi
This network shows the impact of papers produced by Efi Makdasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efi Makdasi. The network helps show where Efi Makdasi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Efi Makdasi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 84 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 50 | |
| 13 | 2021 | 20 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 13 | |
| 17 | 2017 | 15 | |
| 18 | 2013 | 7 | |
| 19 | 2009 | 5 | |
| 20 | 2009 | 4 |
About Efi Makdasi
Efi Makdasi is a scholar working on Infectious Diseases, Immunology and Virology, having authored 27 papers that have together received 299 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), Animal Virus Infections Studies (4 papers), Bacillus and Francisella bacterial research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), COVID-19 Clinical Research Studies (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Infectious Diseases (127 citations), Immunology (90 citations) and Virology (19 citations). Efi Makdasi has collaborated with scholars based in Israel and United States. Frequent co-authors include Ronit Rosenfeld, Nir Paran, Yfat Yahalom-Ronen, Erez Bar‐Haim, Hadas Tamir, Ofer Cohen, Ron Alcalay, Uri Elia, Gonna Somu Naidu and Dan Peer. Their work appears in journals such as Nature Communications, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.